{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:03:45Z","timestamp":1790139825976,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jhep.2026.08.027","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:15:28Z","timestamp":1788362128000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging strategies for hepatocellular carcinoma surveillance: Abbreviated MRI, biomarkers and benefit stratification"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1796-8977","authenticated-orcid":false,"given":"George N.","family":"Ioannou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6641-1430","authenticated-orcid":false,"given":"Peter","family":"Jepsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1288-0749","authenticated-orcid":false,"given":"Ian A.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2026.08.027_bib13","article-title":"Practice changing RCT design and rationale: abbreviated MRI plus AFP vs. ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study)","volume":"8","author":"Ioannou","year":"2026","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.08.027_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000839","article-title":"Abbreviated gadoxetic acid-enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: a randomized trial protocol","volume":"9","author":"Park","year":"2025","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.08.027_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-083701","article-title":"Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer","volume":"14","author":"Nahon","year":"2024","journal-title":"BMJ open"},{"key":"10.1016\/j.jhep.2026.08.027_bib8","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1053\/j.gastro.2024.12.035","article-title":"Noncontrast magnetic resonance imaging vs ultrasonography for hepatocellular carcinoma surveillance: a randomized, single-center trial","volume":"168","author":"Rhee","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.08.027_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000565","article-title":"National liver cancer screening trial (TRACER) study protocol","volume":"8","author":"Singal","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.08.027_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/j.gastro.2025.09.010","article-title":"Utility of serum biomarkers in addition to ultrasound for early detection of hepatocellular carcinoma in high-risk patients: a randomized controlled trial","volume":"170","author":"Hirode","year":"2026","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jhep.2026.08.027_bib20","doi-asserted-by":"crossref","first-page":"e0800","DOI":"10.1097\/HC9.0000000000000800","article-title":"Performance of the multi-target hepatocellular carcinoma blood test: design and rationale of the ALTUS study","volume":"9","author":"John","year":"2025","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.08.027_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2026.04.012","article-title":"A multi-analyte cfDNA-based blood test for early detection of hepatocellular carcinoma","volume":"85","author":"Taggart","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.027_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.027_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1572-0241.2006.00450.x","article-title":"The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI","volume":"101","author":"Shah","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2026.08.027_bib3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamaoncol.2016.3147","article-title":"MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma","volume":"3","author":"Kim","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhep.2026.08.027_bib4","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00261-017-1339-5","article-title":"Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma","volume":"43","author":"Lee","year":"2017","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jhep.2026.08.027_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2214\/AJR.14.12986","article-title":"Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance","volume":"204","author":"Marks","year":"2015","journal-title":"Ajr"},{"key":"10.1016\/j.jhep.2026.08.027_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.crad.2017.11.013","article-title":"Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening","volume":"73","author":"Tillman","year":"2018","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jhep.2026.08.027_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00261-016-0841-5","article-title":"Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid","volume":"42","author":"Besa","year":"2017","journal-title":"Abdom Radiol (Ny)"},{"key":"10.1016\/j.jhep.2026.08.027_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3348\/jksr.2024.0153","article-title":"Abbreviated MRI-based surveillance strategies for early hepatocellular carcinoma detection","volume":"86","author":"Park","year":"2025","journal-title":"J Korean Soc Radiol"},{"key":"10.1016\/j.jhep.2026.08.027_bib10","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1007\/s00330-020-07014-1","article-title":"Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening","volume":"30","author":"Vietti","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2026.08.027_bib11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/HEP.0000000000000339","article-title":"Screening of liver cancer with abbreviated MRI","volume":"78","author":"Ronot","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.08.027_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cgh.2021.02.036","article-title":"Noncontrast MRI for hepatocellular carcinoma detection: a systematic review and meta-analysis - a potential surveillance tool?","volume":"20","author":"Chan","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.08.027_bib15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jamainternmed.2023.3781","article-title":"Testing whether cancer screening saves lives: implications for randomized clinical trials of multicancer screening","volume":"183","author":"Welch","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jhep.2026.08.027_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.gastro.2024.09.008","article-title":"A phase 3 biomarker validation of GALAD for the detection of hepatocellular carcinoma in cirrhosis","volume":"168","author":"Marsh","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.08.027_bib19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2025.09.023","article-title":"HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort","volume":"84","author":"El-Serag","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.027_bib22","series-title":"Performance of a multi-target blood test versus ultrasound in detecting early hepatocellular carcinoma: results from the ALTUS prospective study. Presented at the Liver Meeting, November 2025","author":"John","year":"2025"},{"key":"10.1016\/j.jhep.2026.08.027_bib23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of biomarker development for early detection of cancer","volume":"93","author":"Pepe","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2026.08.027_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2026.06.012","article-title":"Prior surveillance can bias cross-sectional validation of novel HCC biomarkers: incumbent test bias","author":"Ioannou","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.027_bib25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/j.gastro.2025.08.021","article-title":"Changes in liver disease etiology support a lower alpha-fetoprotein threshold for hepatocellular carcinoma screening","volume":"170","author":"Kim","year":"2026","journal-title":"Gastroenterology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782602876X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782602876X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:20:45Z","timestamp":1790137245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882782602876X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"alternative-id":["S016882782602876X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.08.027","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging strategies for hepatocellular carcinoma surveillance: Abbreviated MRI, biomarkers and benefit stratification","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}